Motus GI
Fort Lauderdale
Florida
United States
Tel: 908-996-0239
About Motus GI
Motus GI Holdings, Inc. is a medical technology company dedicated to improving endoscopy outcomes and experiences.
YEAR FOUNDED:
2010
LEADERSHIP:
CEO: Mark Pomeranz
CFO: Andrew Taylor
PRODUCTS:
107 articles about Motus GI
-
Motus GI Reports Second Quarter 2022 Financial Results and Provides Business Update
8/11/2022
Motus GI Holdings, Inc. reported its financial results for the second quarter ended June 30, 2022, and provided a corporate update.
-
Motus GI Regains Compliance with Nasdaq Minimum Bid Price Requirement
8/11/2022
Motus GI Holdings, Inc. announced that it received formal notice from the Nasdaq Stock Market stating that the Company has regained compliance with the minimum bid price requirement ) for continued listing on Nasdaq and that Motus GI’s common stock will continue to be listed and traded on Nasdaq.
-
Motus GI Announces 1-FOR-20 Reverse Stock Split
7/25/2022
Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that it will effect a 1-for-20 reverse stock split of its outstanding common stock.
-
Motus GI to Release Second Quarter Results and Provide a Business Update on August 11
7/21/2022
Motus GI Holdings, Inc., a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced that the Company will release its second quarter financial results on Thursday, August 11, 2022, after the market close.
-
Motus GI Reports First Quarter 2022 Financial Results and Provides Business Update
5/12/2022
Motus GI Holdings, Inc. reported its financial results for the first quarter ended March 31, 2022, and provided a corporate update.
-
Motus GI to Release First Quarter Results and Provide a Business Update on May 12
4/28/2022
Motus GI Holdings, Inc. announced today that the Company will release its first quarter financial results on Thursday, May 12, 2022, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.
-
Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
3/29/2022
Motus GI Holdings, Inc. reported its financial results for the fourth quarter and year ended December 31, 2021, and provided a corporate update.
-
Motus GI to Participate in Two Upcoming Investor Conferences in March 2022
3/2/2022
Motus GI Holdings, Inc. announced that its management team is scheduled to participate in two upcoming investor conferences in March 2022.
-
Motus GI Granted 180-Day Extension to Meet NASDAQ Minimum Bid Price Requirement
2/24/2022
Motus GI Holdings, Inc. announced that the Company received written notification from the Listing Qualification Department of The NASDAQ Capital Market granting the Company's request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550.
-
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System
2/14/2022
Motus GI Holdings, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the Pure-Vu® EVS System.
-
Motus GI to Host Innovation Day Highlighting the Pure-Vu EVS SystemThe innovation day is scheduled to start at 12:30 p.m. ET on Tuesday, January 25th
1/20/2022
Motus GI Holdings, Inc. today announced that it will host an Innovation Day on Tuesday, January 25, 2022, from 12:30 p.m. ET – 2:00 p.m. ET.
-
Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features
12/16/2021
Motus GI Holdings, Inc. announced that the U.S. Patent and Trademark Office has issued patent no. 11,185,625, which is titled, “Colon cleaning system with automatic self-purging features.”.
-
Motus GI to Present at Two Upcoming Investor Conferences in December 2021
11/23/2021
Motus GI Holdings, Inc. announced today that its management team is scheduled to present at two upcoming investor conferences in December 2021.
-
Motus GI Announces Presentation of Results from Independent Study of Pure-Vu System in IBP Patients at the 2021 ACG Annual Scientific Meeting
10/26/2021
Motus GI Holdings, Inc. announced that results from an independent single-center study of the Pure-Vu System as an adjunct to colon cleansing in patients with inadequate bowel preparation were featured in a poster presentation at the 2021 American College of Gastroenterology Annual Scientific Meeting.
-
Motus GI to Present at the Oppenheimer & Co. Inc. Fall Healthcare Summit
9/13/2021
Motus GI Holdings, Inc. announced today that its management team is scheduled to present at the Oppenheimer & Co. Inc. Fall Healthcare Summit.
-
Motus GI to Participate in Two Upcoming Investor Conferences in September 2021
9/7/2021
Motus GI Holdings, Inc. announced today that its management team is scheduled to participate at the two upcoming virtual investor conferences in September 2021.
-
Motus GI Reports Second Quarter 2021 Financial Results and Provides Corporate Update
8/12/2021
Motus GI Holdings, Inc., a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, reported its financial results for the second quarter and six months ended June 30, 2021, and provided a corporate update.
-
Motus GI Secures Expanded $12M Credit Financing to Support Growth Strategy
7/21/2021
Motus GI Holdings, Inc. announced that it has successfully refinanced its debt and expanded its long-term credit facility by securing a new loan agreement with Kreos Capital VI LP for up to $12.0 million, which replaces the previous term loan agreement with Silicon Valley Bank and removes the existing $10.0 million minimum cash balance liquidity covenant.
-
Motus GI Announces First Patients Enrolled in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients With a History of Poor Bowel Preparation
6/16/2021
Motus GI Holdings, Inc. announced today enrollment of the first patients in the European Union (EU) study of the Pure-Vu System.
-
Motus GI’s Pure-Vu System® Adopted by Sinai Hospital of Baltimore
5/25/2021
Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy procedures